This is a StreetInsider.com Premium Only Page

(IRRAS) – Press Releases

Feb 16, 2023 02:14 AM IRRAS AB publishes Year End Report for the period January to December 2022

Feb 13, 2023 03:42 AM IRRAflow System Confirmed to More Effectively Remove Collected Blood and Reduce Catheter Infection Rates than Passive Drainage in Head-to-Head Analysis

Dec 12, 2022 02:40 AM IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit

Nov 14, 2022 12:33 PM IRRAS Announces Commercial Partnership with Medtronic in the United States for its IRRAflow® System

Nov 10, 2022 02:30 AM IRRAS AB publishes Interim Report for the period January to September 2022

Oct 13, 2022 02:54 AM IRRAS Announces Participation and Data Presentation at the 22nd European Congress of Neurosurgery

Oct 11, 2022 02:41 AM IRRAS Announces New Educational Webinar Series in Collaboration with the Jacobs Institute and the University of Buffalo Department of Neurosurgery

Oct 5, 2022 03:07 AM IRRAS Announces Participation and Educational Symposium at Key Upcoming Neurosurgery Conferences

Aug 23, 2022 02:44 AM IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study

Jul 22, 2022 02:18 AM IRRAS AB publishes Interim Report for the period January to June 2022

May 28, 2021 02:43 AM IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage

May 11, 2021 02:52 AM IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and Certifications

May 4, 2021 02:18 AM IRRAS AB publishes Interim Report for the period January to March 2021

Apr 21, 2021 02:07 PM IRRAS Promotes Will Martin to Chief Executive Officer

Apr 6, 2021 02:46 AM IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow

Mar 30, 2021 02:47 AM IRRAS publishes annual report for 2020

Mar 23, 2021 03:24 AM IRRAS to Present at Redeye

Mar 9, 2021 03:00 AM IRRAS Announces the recruitment of Sten Gustafsson as Director of Investor Relations

Feb 16, 2021 02:17 AM IRRAS AB publishes Year End Report for the period January to December 2020

Feb 9, 2021 02:14 AM Q4 Report 2020 - invitation to conference call and audiocast

Jan 12, 2021 02:11 AM IRRAS Announces Collaboration with Karolinska University Hospital

Jan 5, 2021 04:16 AM IRRAS to Present at H.C. Wainwright Virtual BioConnect Conference

Dec 17, 2020 02:21 AM IRRAS Announces Expansion of IRRAflow Launch to Southeastern Europe

Dec 10, 2020 02:24 AM IRRAS Announces Expansion of IRRAflow Launch to Latin America

Nov 26, 2020 02:16 AM IRRAS Announces Expansion of IRRAflow Launch to The Netherlands

Nov 17, 2020 02:26 AM IRRAS Awarded Breakthrough Technology Purchasing Agreement with Premier for Hummingbird ICP Monitoring Products

Nov 10, 2020 02:59 AM IRRAS AB publishes Interim Report for the period January to September 2020

Nov 4, 2020 02:21 AM IRRAS: Q3 Report 2020 - invitation to conference call and audiocast

Oct 22, 2020 05:44 AM IRRAS Announces Key IRRAflow Commercial Milestones in Germany

Sep 29, 2020 04:13 AM IRRAS Announces Release of Clinical Data that Validates Safety and Effectiveness of IRRAflow System in Treating Chronic Subdural Hematomas

Aug 25, 2020 04:13 AM IRRAS Granted Sixth Patent for Hummingbird ICP Monitoring Product Line from United States Patent and Trademark Office (USPTO)

Aug 20, 2020 02:10 AM IRRAS: Q2 Report 2020 - invitation to conference call and audiocast

Aug 11, 2020 04:15 AM IRRAS Announces First Global Patient Treatment with Newly Developed Hummingbird Solo ICP Monitoring System

Jul 22, 2020 03:57 AM IRRAS Announces Extension of CE Mark for IRRAflow System Until May 2024

Jun 30, 2020 04:14 AM COVID-19 Delays Short Term Revenue, While the Commercial Launch of IRRAflow and Hummingbird Progresses

Jun 15, 2020 02:49 AM IRRAS Announces Promotion of Will Martin to President and Chief Commercial Officer

May 19, 2020 11:17 AM IRRAS has Been Approved for Listing on Nasdaq Stockholm and Publishes Prospectus

May 11, 2020 02:27 AM IRRAS: Q1 Report 2020 - Invitation to Conference Call and Audiocast

May 7, 2020 11:45 AM IRRAS to List on Nasdaq Stockholm

Mar 25, 2020 03:17 AM University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow

Mar 20, 2020 11:41 AM IRRAS Publishes Annual Report for 2019

Feb 14, 2020 02:37 AM IRRAS AB Publishes Interim Report for the Period January to December 2019

Jan 30, 2020 03:04 AM IRRAS: Q4 Report 2019 - Invitation to Conference Call and Audiocast

Jan 7, 2020 02:50 AM IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020

Dec 19, 2019 06:30 PM IRRAS Receives Renewed CE Mark for the IRRAflow Catheter

Dec 19, 2019 03:50 PM IRRAS Receives Renewed CE Mark for the IRRAflow Catheter

Dec 16, 2019 02:19 AM IRRAS Announces US Launch of Hummingbird Products for Neurocritical Care

Dec 9, 2019 02:15 AM IRRAflow® Wins CONNECT's "2019 Most Innovative New Product" Award

Nov 21, 2019 03:31 PM IRRAS Announces FDA Clearance of New 510(K) Filing to Expand the Time of Use of IRRAflow®

Nov 14, 2019 02:18 AM IRRAS AB publishes Interim Report for the Period January to September 2019